Scott Uebele brings nearly fifteen years of pharma-services expertise including executive-level strategic operations, industry knowledge and financial leadership to his position as president and chief research services officer. In this role, he provides strategic direction and oversight for Institutional Review Board (IRB), Institutional Biosafety Committee (IBC) and Consulting Services, operations, regulatory services, informatics, and the related business development and customer relationships teams.
Most recently at Advarra, Uebele was the executive in charge of consulting and held the position of chief financial officer (CFO), overseeing the financial, legal, analytics, and contracts activities. He will continue in the CFO role on an interim basis until his replacement is named.
Prior to Advarra, Uebele served as chief financial officer at Chesapeake IRB and was the global vice president of finance for Research Pharmaceutical Services (RPS), a global clinical research organization now part of PRA Health Sciences. In the latter role, Uebele provided executive oversight finance, analysis and reporting functions, including personnel and deliverables in 68 countries. He has also served in multiple financial and operational roles for both mid-cap and Global 500 organizations.
Uebele earned his bachelor’s degree in economics from Bucknell University and his MBA in finance from Seton Hall University, where he was awarded the Robert Troccoli Business Policy Award.